The affected
Thermo Fisher Applied Biosystems Genetic Analyzers are vulnerable because .fsa/.hid output files can be edited. An attacker could tamper with these files, altering DNA data and resulting in inaccurate DNA test outcomes.
Score 8.4 from GitHub Security Advisory (severity: HIGH) published 2026-08-05. a secondary CVSS source baseline 8.4; sources differ by 0.0.
No vendor fix yet — apply a workaround or compensating control (WAF / firewall / segmentation) and watch for a patch.
The affected
Thermo Fisher Applied Biosystems Genetic Analyzers are vulnerable because .fsa/.hid output files can be edited. An attacker could tamper with these files, altering DNA data and resulting in inaccurate DNA test outcomes.
EG Risk is EchelonGraph's 0–100 priority score: it fuses intrinsic severity with real-world exploitation and automatability so you can rank equal-severity CVEs and fix the most dangerous first. Higher = act sooner. Distinct from the 0–10 EG Score (severity).
August 5, 2026
August 6, 2026
Thermo Fisher Applied Biosystems Genetic Analyzers | CISA. Listed in CISA Known Exploited Vulnerabilities catalog.
https://www.cisa.gov/news-events/ics-medical-advisories/icsma-26-216-01These vendors published their own advisory mentioning this CVE — often with vendor-specific remediation steps + affected product lists not in NVD.
MITRE Common Weakness Enumeration — the root-cause categories this CVE belongs to.
Each row is a source pipeline that fetched or updated this CVE on that date, with what changed. For example, "NVD update" means NVD published or revised its analysis for this CVE; "MITRE cvelistV5" means we ingested or refreshed it from the CNA feed. Most recent first.
Explore the affected products and dependency analysis for CVE-2026-17583
EchelonGraph automatically scans your cloud infrastructure and maps CVE exposure using blast radius analysis.